Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Accelerate Diagnostics Inc (Symbol: AXDX), where a total of 1,450 contracts have traded so far, representing approximately 145,000 underlying shares. That amounts to about 53.2% of AXDX's average daily trading volume over the past month of 272,490 shares. Especially high volume was seen for the $22.50 strike put option expiring March 16, 2018 , with 450 contracts trading so far today, representing approximately 45,000 underlying shares of AXDX. Below is a chart showing AXDX's trailing twelve month trading history, with the $22.50 strike highlighted in orange:
McDonald's Corp (Symbol: MCD) saw options trading volume of 30,572 contracts, representing approximately 3.1 million underlying shares or approximately 52.6% of MCD's average daily trading volume over the past month, of 5.8 million shares. Especially high volume was seen for the $160 strike call option expiring March 16, 2018 , with 1,956 contracts trading so far today, representing approximately 195,600 underlying shares of MCD. Below is a chart showing MCD's trailing twelve month trading history, with the $160 strike highlighted in orange:
And Global Blood Therapeutics Inc (Symbol: GBT) options are showing a volume of 4,081 contracts thus far today. That number of contracts represents approximately 408,100 underlying shares, working out to a sizeable 51.4% of GBT's average daily trading volume over the past month, of 793,440 shares. Particularly high volume was seen for the $55 strike put option expiring March 16, 2018 , with 578 contracts trading so far today, representing approximately 57,800 underlying shares of GBT. Below is a chart showing GBT's trailing twelve month trading history, with the $55 strike highlighted in orange:
For the various different available expirations for AXDX options , MCD options , or GBT options , visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
